BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8344891)

  • 1. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites.
    Ferrari S; Pearson RB; Siegmann M; Kozma SC; Thomas G
    J Biol Chem; 1993 Aug; 268(22):16091-4. PubMed ID: 8344891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases.
    Dennis PB; Pullen N; Kozma SC; Thomas G
    Mol Cell Biol; 1996 Nov; 16(11):6242-51. PubMed ID: 8887654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites.
    Han JW; Pearson RB; Dennis PB; Thomas G
    J Biol Chem; 1995 Sep; 270(36):21396-403. PubMed ID: 7545671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple independent inputs are required for activation of the p70 S6 kinase.
    Weng QP; Andrabi K; Kozlowski MT; Grove JR; Avruch J
    Mol Cell Biol; 1995 May; 15(5):2333-40. PubMed ID: 7739516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p70s6k/p85s6k: mechanism of activation and role in mitogenesis.
    Kozma SC; Thomas G
    Semin Cancer Biol; 1994 Aug; 5(4):255-60. PubMed ID: 7803761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p70 S6 kinase sensitivity to rapamycin is eliminated by amino acid substitution of Thr229.
    Sugiyama H; Papst P; Gelfand EW; Terada N
    J Immunol; 1996 Jul; 157(2):656-60. PubMed ID: 8752914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis.
    Thomas G
    Biochem Soc Trans; 1993 Nov; 21(4):901-4. PubMed ID: 8132090
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.
    Pearson RB; Dennis PB; Han JW; Williamson NA; Kozma SC; Wettenhall RE; Thomas G
    EMBO J; 1995 Nov; 14(21):5279-87. PubMed ID: 7489717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Drosophila p70s6k homolog exhibits conserved regulatory elements and rapamycin sensitivity.
    Stewart MJ; Berry CO; Zilberman F; Thomas G; Kozma SC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10791-6. PubMed ID: 8855259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the immunosuppressant rapamycin.
    Dumont FJ; Su Q
    Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells.
    Seufferlein T; Rozengurt E
    Cancer Res; 1996 Sep; 56(17):3895-7. PubMed ID: 8752154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast.
    Migita K; Eguchi K; aoyagi T; Tsukada T; Tsuboi M; Kawabe Y; Nagataki S
    Clin Exp Immunol; 1996 Apr; 104(1):86-91. PubMed ID: 8603539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.
    Jefferies HB; Fumagalli S; Dennis PB; Reinhard C; Pearson RB; Thomas G
    EMBO J; 1997 Jun; 16(12):3693-704. PubMed ID: 9218810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of p70 s6 kinase by kinase activity of FRAP in vivo.
    Brown EJ; Beal PA; Keith CT; Chen J; Shin TB; Schreiber SL
    Nature; 1995 Oct; 377(6548):441-6. PubMed ID: 7566123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
    Jefferies HB; Reinhard C; Kozma SC; Thomas G
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4441-5. PubMed ID: 8183928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Sadoshima J; Izumo S
    Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
    Patel HR; Terada N; Gelfand EW
    Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
    Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
    Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.
    von Manteuffel SR; Gingras AC; Ming XF; Sonenberg N; Thomas G
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4076-80. PubMed ID: 8633019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.